期刊文献+

乙肝五项时间分辨免疫荧光分析与PCR-HBV定量的关系 被引量:2

乙肝五项时间分辨免疫荧光分析与PCR-HBV定量的关系
下载PDF
导出
摘要 目的研究乙肝血清标志物时间分辨免疫定量检测结果与HBV-DNA定量之间的关系。方法将200例血清标本同时采用时间分辨免疫荧光定量和实时荧光定量PCR技术,对乙肝五项含量和HBV-DNA含量分别进行检测,按照不同的乙肝病毒标志模式情况分组后,进行乙肝病毒标志物与HBV-DNA的分析研究。结果乙肝病毒标志物HBsAg、HBeAg、HBcAb阳性组HBV-DNA检出率为98.7%,HBsAg、HBeAb、HBcAb阳性组检出率59.3%,HBcAb单项阳性组检出率50%,HBsAb阳性组检出率0,全阴性组检出率0。结论时间分辨免疫荧光分析与HBV-DNA关系密切,两者联用能更好的满足临床需求。 Objective To investigate the relationships between HBV infected patients'immunological marker detected by time-resolved fluoroimmunoassay(TRFIA)quantitatively and HBV-DNA concentrations.Methods Two hundred samples were detected by TRFIA and real-time quantitative PCR simultaneously.According to different HBV marker pattern,results were divided into several categories and analyzed comparatively with HBV-DNA level.Results In patients with HBsA(g+)/HBeAg(+)/HBcAb(+),HBsAg(+)/HBeAb(+)/HBcAb(+),HBcAb(+),HBsAb(+)and HBV-M-negative,the HBV-DNA positive rate were 98.7%,59.3%,50%,0,0,respectively.Conclusion TRFIA and HBV-DNA had a close relationship.TRFIA in combination with HBV-DNA can meet the need of Clinic better.
出处 《中外医疗》 2008年第34期18-19,共2页 China & Foreign Medical Treatment
关键词 时间分辨免疫荧光分析 实时荧光定量PCR Time-resolved fluoroimmunoassay Real-time quantitative PCR
  • 相关文献

参考文献8

  • 1[1]Kuhns MC,et al.New Strategies for Blood Donor Screening for Hepatitis B Virus:Nucleic Acid Testing versus Immunoassay Methods[J].Mol Diag Ther.2006,10(2):77~91.
  • 2[2]Biswas R,et al.Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.Transfusion[J].2003,43:788~798.
  • 3[3]Kuhns MC,et al.Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc:implications for future HBV screening policy[J].Transfusion.2004,44:1332~1339.
  • 4[4]Allain JP,et al.Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors[J].Transfusion.2005,45:1039~1040.
  • 5[5]Sato S,et al.Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay[J].Transfusion.2001,41:1107~1113.
  • 6[6]Allain JP.Occult hepatitis B infection:implications in transfusion[J].Vox Sang,2004,86:83~91.
  • 7[7]Busch MP.Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors[J].Transfus Clin Biol.2004,11:26~32.
  • 8[8]Kleinman SH,et al.Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc:implications for transfusion transmission and donor screening[J].Transfusion.2003,43:696~704.

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部